The current stock price for Adaptimmune Therapeutics Plc ADR (ADAP) is $0.06. The stock experienced a significant increase during the last trading session, reaching $1.5 after opening at $0.06. It dipped to a low of $0.09 before ultimately closing at $0.07.
The stock market performance of Adaptimmune Therapeutics Plc ADR has been fairly unsteady. Over the last year, the company’s stock hit its highest at $1.33 on 08/26/24, while the lowest price during the same time frame was $0.07, recorded on 08/15/25.
52-week price history of ADAP Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Adaptimmune Therapeutics Plc ADR’s current trading price is -95.53% away from its 52-week high, while its distance from the 52-week low is -13.52%. The stock’s price range for this period has remained between $0.07 and $1.33. The Healthcare sector company’s shares managed to surpass a trading volume of around 35.46 million for the day, which was noticeably higher compared to the shares’ average daily volume of 18.03 million over the last three months.
Financial Performance and Market Capitalization
Adaptimmune Therapeutics Plc ADR (ADAP) has experienced a quarterly decline of -77.52% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 15.77M and boasts a workforce of 506 employees.
Analysts’ Ratings For Adaptimmune Therapeutics Plc ADR
As of right now, 0 analyst is rating Adaptimmune Therapeutics Plc ADR as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 4 analysts are recommending to HOLD this stock, 1 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.2384, with a change in price of -0.2173. Similarly, Adaptimmune Therapeutics Plc ADR recorded 12,523,516 in trading volume during the last 100 days, posting a change of -78.50%.
ADAP Stock Stochastic Average
As of today, the raw stochastic average of Adaptimmune Therapeutics Plc ADR over the past 50 days is 0.07%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 0.07%. Additionally, the Stochastic %K and %D values for the company were 1.33% and 2.18%, respectively, over the past 20 days.
ADAP Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. The metric has seen a significant loss of -94.33% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -89.68%. Over the past 30 days, the price of ADAP has leaped by -78.48%. And in the last five days, it has fallen by -23.23%.
